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Captive and free-ranging wildlife animals are implicated in the maintenance and transmission of bovine
tuberculosis and therefore pose a significant obstacle to eradication of the disease from domestic livestock. The
current antemortem diagnostic method, the intradermal tuberculin skin test, is impractical for routine use
with many wild animals. Antibody-based assays are particularly attractive because the animals are handled
only once and immediate processing of the sample is not required. This report characterizes the antibody
responses of red deer-elk hybrids (Cervus elaphus) against Mycobacterium bovis and subsequently evaluates the
diagnostic performance of select antigens in a rapid-test format. Sequential serum samples were collected from
10 animals experimentally infected with M. bovis and 5 noninfected animals over a 7-month period postinfec-
tion (p.i.). Samples were evaluated by enzyme-linked immunosorbent assays, immunoblot analyses, and
multiantigen print immunoassays for seroreactivity to mycobacterial antigens. Although all infected animals
produced antibodies to M. bovis protein antigens, there was significant animal-to-animal variation in the
kinetics and magnitudes of responses and the antigens recognized. The most frequently recognized antigens
included MPB83, ESAT-6, CFP10, and MPB70. Responses to some antigens, such as MPB83, were consistently
detected as early as 4 weeks after inoculation, whereas other antigens were detected only much later (>140 days
p.i.). Antibody responses were boosted by injection of tuberculin for intradermal tuberculin skin testing.
Comparison of single-antigen (fluorescence polarization assay) with multiantigen (CervidTB STAT-PAK)
rapid tests demonstrated that a highly sensitive and specific serodiagnostic test for tuberculosis in cervids will
require multiple and carefully selected seroreactive antigens covering a broad spectrum of antibody
specificities.
Mycobacterium bovis, the etiological agent of bovine tuber-
culosis (TB), has an extraordinarily broad mammalian host
range that includes humans, domestic livestock, and wildlife.
Globally, several wildlife species have been implicated in the
maintenance and transmission of M. bovis. In North America,
these include white-tailed deer (Odocoileus virginianus) in
northeastern Michigan (37), elk (Cervus elaphus) in and
around Riding Mountain National Park, Manitoba, Canada
(31), and wood bison (Bison bison athabascae) in and around
Wood Buffalo National Park, Alberta, Canada, and the North-
west Territories (31). The continued transmission of M. bovis
from free-ranging wildlife reservoirs to domestic livestock re-
sults in significant economic losses and is a significant barrier
to the success of national eradication and control programs (5).
Similarly, TB agent-infected captive wildlife maintained in
farms or animal parks (e.g., zoos or game farms) may also serve
as foci of infection for domestic animals, free-ranging wildlife,
and humans (7, 42). The existing methods for diagnosing bo-
vine TB that rely on cell-mediated immune reactivity are either
inadequate, not fully developed, or not validated for use in
wildlife. The most frequently employed antemortem test, the
tuberculin skin test, involves the intradermal administration of
a tuberculin which is composed of poorly defined mycobacte-
rial antigens, some of which are highly cross-reactive with
other environmental nontuberculous Mycobacterium spp. (29).
Other limitations of this test include anergic responses in an-
imals with high bacterial loads (20) and a requirement for
handling animals twice over a 72-hour period. The additional
handling increases the risk of capture-associated injuries to
which wildlife are particularly prone.
For these reasons, alternative diagnostic approaches that are
both accurate and efficient are required. A stand-alone “ani-
mal-side” blood-based test for antemortem detection of M.
bovis is particularly appealing for TB surveillance programs of
nontraditional livestock and wildlife. In vitro assays of cell-
mediated immunity, such as the gamma interferon enzyme-
linked immunosorbent assay (ELISA), have shown promise in
this regard for Mycobacterium tuberculosis and M. bovis infec-
tion of humans (6) and cattle (36), respectively. They remain,
however, complex tests that require processing of the blood
sample within 24 h, are subject to complications associated
with overnight delivery (e.g., temperature fluctuations and de-
lays) (46), and involve an antigen stimulation step necessitating
at least one working day to complete the test. Serological
assays, in contrast, are rapid, inexpensive, easy to perform, and
not subject to the sampling and processing variables of cellular
assays, making them well suited to field sampling.
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To date, no assay detecting circulating antibody to M. bovis
has shown adequate sensitivity or specificity suitable for stand-
alone routine diagnostic use. Early attempts to apply serolog-
ical assays to diagnosis of TB were hampered by considerable
technical difficulties related to the choice of antigens, the im-
munoassay format, the phase of the infection, and the antibody
isotype involved in the response. These initial assays used
highly cross-reactive antigen preparations of M. bovis, such as
crude cell sonicate (10), culture filtrate (34), purified protein
derivative (PPD) from heat-killed cultures (12), and lipoarabi-
nomannan (LAM) (40). In general, a lack of specificity was
reported when these antigens were used, and the distribution
of antibody titers between infected and noninfected individuals
was widely overlapping. Subsequent attempts at using TB com-
plex-specific antigens increased specificity but provided detec-
tion of serological responses in only a minority of infected
animals (13). More recently, several additional protein anti-
gens have been serologically characterized and display immu-
nological specificity to M. bovis or the M. tuberculosis complex
(27, 28). With such information, the use of antigen cocktails for
TB diagnosis has shown promise in improving sensitivity (25)
while maintaining high specificity (2). Studies to date, however,
have shown variable animal-to-animal and species-to-species
antigen recognition patterns (27, 45). As a result, the develop-
ment of serological TB assays for wildlife species will require
specific information about the antigens recognized by antibod-
ies that are produced during M. bovis infection.
This report characterizes the antibody response of red deer-
elk (Cervus elaphus) hybrid Cervidae to experimental infection
with M. bovis. Several immunoassays were used to establish the
kinetics and nature of reactivity of serum antibodies to crude
mycobacterial antigens and a panel of highly purified recom-
binant proteins of M. bovis/M. tuberculosis. The effect of tuber-
culin skin testing on antibody response was also examined.
Finally, the abilities of two serological rapid tests to correctly
identify M. bovis-infected animals over the course of experi-
mental infection were evaluated. The first, a lateral-flow im-
munoassay (CervidTB STAT-PAK), detects antibody reactivity
to a mixture of target antigens (11, 26). This protocol was
compared to a fluorescence polarization assay (FPA) specific
for an MPB70 epitope previously developed for the detection
of M. bovis antibodies in the sera of elk, bison, cattle, and
llamas (41).
MATERIALS AND METHODS
Animals and infection. Fifteen healthy red deer (Cervus elaphus elaphus)-elk
(Cervus elaphus nelsoni) hybrids of approximately 4 weeks of age were weaned
and obtained from a herd with no history of TB and moved to the Ottawa
Laboratory Fallowfield (OLF), Canadian Food Inspection Agency (CFIA),
Ottawa, Ontario, Canada. Prior to the infection study, an outline of all procedures
was approved by a CFIA Institutional Animal Care and Use Committee and was
confirmed to be in accordance with the humane animal treatment requirements
of the Canadian Council on Animal Care. At 8 months of age, 2 months prior to
the experimental infection, animals were screened using a lymphocyte prolifer-
ation assay (15) against M. bovis, M. avium, and M. avium subsp. paratuberculosis
tuberculins (PPD-bovis, PPD-avium, and PPD-Johnin, respectively; Biologics
Production Unit, CFIA, Ottawa, Ontario, Canada) to confirm their TB-free
statuses. For the duration of the study, 10 M. bovis-inoculated animals were
housed in temperature- and humidity-controlled rooms (two or three animals per
room) within a biosafety level 3 confinement facility. For the same duration, five
control animals were housed within the same biosafety level 3 confinement
facility and were treated similarly. Prior to inoculation, all animals were allowed
to acclimate to their new environment for 2 weeks. Ten experimental red deer-
elk hybrids were inoculated with a field strain of M. bovis (02/1007 [CFIA
designation]) originally isolated from a beef cow in the Grandview, Manitoba
area located adjacent to Riding Mountain National Park and possessing a spo-
ligotype strain pattern identical to that reported for TB agent-infected wild elk
from within the park (22). The challenge inoculum consisted of 1.5  103 CFU
of mid-log-phase M. bovis grown in Middlebrook 7H9 media supplemented with
10% oleic acid-albumin-dextrose-citrate (Becton Dickinson, Mississauga,
Ontario, Canada). To harvest tubercle bacilli from culture media, cells were pelleted
by centrifugation at 750  g, washed twice with 1 ml of phosphate-buffered saline
(PBS; pH 7.2), and resuspended in PBS to an appropriate cell density for
inoculation of 2 ml. After resuspension in PBS solution, serial 10-fold dilutions
were inoculated on Middlebrook 7H10 agar slants supplemented with oleic
acid-albumin-dextrose-citrate to confirm retrospectively the number of CFU
administered. The challenge inoculum was instilled directly into the tonsillar
crypts of anesthetized animals as previously described (33). Control cervids were
treated similarly except that normal saline was instilled into tonsillar crypts. TB
agent infection status was confirmed for all animals by careful postmortem
examination and tissue sampling followed by mycobacterial culture and histopa-
thology for acid-fast bacilli. All inoculated animals were positively infected, as M.
bovis was isolated from sampled tissues and microscopic lesions consistent with
TB contained acid-fast bacilli. Control animals remained uninfected, as tuber-
culous lesions were not identified, nor was M. bovis isolated. A detailed descrip-
tion of these methods has previously been described (32), and the results, in-
cluding those for molecular testing by the amplified M. tuberculosis direct test
(Gen-Probe, Inc., San Diego, CA) and spoligotyping (16), confirming that the M.
bovis isolates were identical to the original inoculum, will be presented in a later
publication.
Tuberculin skin testing. At 184 days postinoculation (p.i.), the in vivo delayed-
type hypersensitivity reactions of control and inoculated animals to mycobacte-
rial antigens were measured by the comparative cervical intradermal skin test
(CCT). Briefly, hair was clipped from two sites on one side of the mid-cervical
region, and the skin thickness of each site was measured. In the uppermost site,
0.1 ml of PPD-avium (0.5 mg/ml) was injected intradermally and 0.1 ml of
PPD-bovis (1 mg/ml) was injected into the lower site. Tuberculins for skin test
procedures were obtained from the Biologics Production Unit at the CFIA,
Ottawa, Ontario, Canada. Injection sites were observed, palpated, and measured
(Digimatic calipers; Mitutoyo Corporation, Tokyo, Japan) 72 h after injection.
All measurements were performed in triplicate, and the average preinjection skin
thickness (mm) readings were subtracted from the posttest readings to give
values for both PPD-bovis and PPD-avium. Animals were categorized as nega-
tive, suspect, or reactor by plotting measurements on a scattergram developed by
the CFIA for interpretation of the CCT for Cervidae.
ELISAs. Serological responses to LAM and PPD-bovis were evaluated by
ELISAs in two laboratories, the National Animal Disease Center (NADC;
USDA, Ames, IA) and the OLF (CFIA, Ottawa, ON, Canada) for LAM and
PPD-bovis responses, respectively. These evaluations, described below, differed
in terms of reagents (antigens and conjugates), test methodologies, and manners
in which results were reported.
The LAM ELISA performed at the NADC involved the preparation of LAM-
enriched antigens from M. bovis strain 95-1315 at the NADC as previously
described (47). Immunlon II 96-well microtiter plates (Dynatech, Chantilly, VA)
were coated with 100 l/well (4 g) of LAM-enriched antigen diluted with 0.01
M carbonate buffer (pH 9.6) and allowed to stand overnight at 4°C. Plates were
washed three times with 200 l/well PBS containing 0.05% Tween 20 (PBST;
Sigma) and blocked with 200 l/well commercial milk diluent/blocking solution
(Kirkegaard and Perry Laboratories, Gaithersburg, MD). After incubation for
1 h at 37°C in the blocking solutions, wells were washed nine times with 200 l/ml
PBST and test sera were added to the wells (100 l/well). Test and control sera
were diluted 1:100 in PBS containing 0.1% gelatin. Optimal dilutions of test sera
were determined by evaluation of the reactivity of twofold serial dilutions rang-
ing from 1:6 to 1:800 (volume of sera/volume of diluent ratio) with each of the
antigens (47). After incubation for 20 h at 4°C with diluted test sera, the wells
were washed nine times with 200 l/well PBST and incubated for 1 h at 37°C with
100 l/well horseradish peroxidase-conjugated polyclonal anti-cervine immuno-
globulin G (IgG; heavy and light chains; Kirkegaard and Perry Laboratories)
diluted 1:500 in PBS plus 0.1% gelatin. The wells were washed nine times with
200 l/well PBST and incubated for 4.5 min at room temperature with 100
l/well SureBlue 3,35,5-tetramethyl benzidine (TMB) substrate (Kirkegaard
and Perry Laboratories). The reaction was stopped by the addition of 100 l/well
0.18 M sulfuric acid, and the A450s of individual wells were measured with an
automated ELISA plate reader (Molecular Devices, Menlo Park, CA). The
optical density (OD) changes (OD) were calculated by subtracting the mean
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OD readings for wells receiving coating buffer alone (two replicates) from the
mean OD readings for antigen-coated wells (two replicates) receiving the same
serum sample.
The PPD-bovis ELISA performed at the OLF used a trichloroacetic acid
precipitate of PPD-bovis antigen prepared by the Biologics Production Unit
(CFIA, Ottawa, Ontario, Canada). Round-bottom 96-well polystyrene plates
(Nunc Maxisorb, Roskilde, Denmark) were coated with PPD-bovis at 1 g/ml in
0.05 M carbonate buffer, pH 9.6. Immediately after the antigen was dispensed,
the plates were frozen at 20°C and stored until used. All steps following antigen
coating were conducted at room temperature. The wash and conjugate buffer was
0.01 M Tris, 0.15 M NaCl, pH 8.0, containing 0.05% Tween 20 and was used for
sample dilution with the addition of 0.02% NaN3. The test conditions consisted
of overnight serum incubation with test samples diluted to 1:1,000 (100 l/well).
Washing of test samples was followed by 6 h of incubation with a conjugate (an
alkaline phosphatase-labeled recombinant G protein [Zymed Laboratories, Inc.,
South San Francisco, CA]). The substrate p-nitrophenyl phosphate (Sigma, St.
Louis, MO) was added to diethanolamine buffer 20 min before use and the
solution mixed well prior to use. Each plate was read in a kinetic assay with a
microplate reader (Thermomax; Molecular Devices Corporation, Sunnyvale,
CA), and any between-plate variation was corrected for using standards included
on each plate. The test results are presented as slope values (milli-OD values/
min) determined by using SOFTmax PRO software (Molecular Devices Corpo-
ration).
Electrophoresis and immunoblot assay. The antibody responses of cervids
were evaluated over time by electrophoresis and immunoblot analysis using
procedures described previously (1), with the following modifications. The anti-
gens used for immunoblot analysis included a whole-cell sonicate (WCS) of M.
bovis strain 95-1315 prepared as previously described (44) and recombinant
MPB83 protein (Veterinary Sciences Division, Agri-Food and Biosciences Insti-
tute, Belfast, Northern Ireland). The antigen was electrophoresed through pre-
parative 12% (wt/vol) polyacrylamide gels. Electrophoretic transfer of proteins
onto pure nitrocellulose was accomplished with a Bio-Rad Trans Blot cell (Bio-
Rad Laboratories, Mississauga, ON, Canada), using sodium phosphate buffer (25
mM, pH 7.8) at 0.8 A for 90 min. After transfer, the filters were blocked with
PBST and 2% (wt/vol) bovine serum albumin (PBST-BSA). After being blocked,
the filters were placed into a 20-slot mini-protean multiscreen device (Bio-Rad)
and individual sera diluted 1:200 in PBST-BSA were added to independent slots.
After 2 h of incubation at room temperature with gentle rocking, the blots were
washed three times with PBST and incubated with horseradish peroxidase-
conjugated polyclonal anti-cervine IgG (heavy and light chains; Kirkegaard and
Perry Laboratories) diluted 1:20,000 in PBST-BSA for 1.5 h. The blots were
again washed three times with PBST and developed for chemiluminescence in
SuperSignal detection reagent (Pierce Chemical Co.).
Multiantigen print immunoassay (MAPIA). The following recombinant anti-
gens of M. tuberculosis/M. bovis were purified to near homogeneity as polyhisti-
dine-tagged proteins (designated by Rv numbers according to the classification
of Cole et al. [4]): ESAT-6 (Rv3875) and CFP10 (Rv3874), produced at the
Statens Serum Institut, Copenhagen, Denmark, and MPB59 (Rv1886c; a com-
ponent of the Ag85 complex), MPB64 (Rv1980c), MPB70 (Rv2875), and MPB83
(Rv2873), produced at the Veterinary Sciences Division (Agri-Food and Bio-
sciences Institute, Belfast, Northern Ireland). The 16-kDa alpha-crystalline pro-
tein (Acr1; Rv2031c) and the 38-kDa protein (PstS1; Rv0934) were purchased
from Standard Diagnostics, Seoul, South Korea. Polyprotein fusions of ESAT-
6/CFP10 and Acr1/MPB83 were constructed at the Statens Serum Institut by
overlapping PCR using gene-specific oligonucleotides to amplify the genes from
M. tuberculosis H37Rv chromosomal DNA. Mycobacterium bovis culture filtrate
protein (MBCF) was obtained from a field strain of M. bovis (T/91/1378 [Vet-
erinary Sciences Division]; cultured in synthetic Sauton’s medium).
The MAPIA was performed as described previously (28), with the following
modifications. Purified antigens were immobilized at a protein concentration of
0.05 mg/ml on strips of nitrocellulose membrane (Schleicher & Schuell, Keene,
NH) to generate invisible parallel bands. Strips were blocked for 1 h with 1%
nonfat skim milk in PBST and then incubated for 1 h at room temperature with
individual serum samples diluted 1:50 in blocking solution. After being washed,
the strips were incubated for 1 h at room temperature with peroxidase-conju-
gated protein G (Sigma) diluted 1:1,000 (Kirkegaard and Perry Laboratories),
followed by another washing step. Cervid IgG antibodies bound to immobilized
antigens were visualized with TMB (Kirkegaard and Perry Laboratories). The
MAPIA results were scored by two independent operators, with a band of any
intensity being read as a positive reaction.
Lateral-flow rapid test. A rapid immunochromatographic assay (CervidTB
STAT-PAK test; Chembio Diagnostic Systems, Inc., Medford, NY) was evalu-
ated for its ability to detect antibodies from experimentally inoculated animals.
The test employed a cocktail of selected M. tuberculosis and/or M. bovis antigens,
including ESAT-6, CFP-10, and MPB83, with a blue latex bead-based signal
detection system (26). The test was performed according to the manufacturer’s
recommended procedure, using 30 l of a serum sample and 3 drops of diluent
buffer (included with the kit) that were added sequentially. The results were read
visually 20 min after addition of diluent. Any visible band in the test area was
considered indicative of an antibody-positive result. The absence of a band in the
test area was considered an antibody-negative result.
FPA rapid test. The FPA was performed as previously described (41), with
some modifications. Briefly, the serum was diluted 1:5 (total volume 1.0 ml) in
PBS (0.01 M phosphate plus 0.85% sodium chloride, pH 7.4) supplemented with
sodium azide (0.1%) and lithium dodecyl sulfate (0.1%) in an 11- by 75-mm
borosilicate glass test tube. The mixture was vortexed and allowed to equilibrate
for 2 h at room temperature, after which a blank reading was obtained with a
fluorescence polarization analyzer (Sentry model; Diachemix LLC, Grayslake,
IL). An aliquot of fluorescein-labeled MPB70 protein (sufficient to yield a total
fluorescence intensity between 300,000 and 400,000 millipolarization [mP] val-
ues) was then added and the mixture vortexed. After equilibration for 30 min at
room temperature, the blank-subtracted fluorescence mP value was measured.
Sera from known infected and uninfected elk were included as positive and
negative controls, respectively, in each batch of sera tested. All sera were tested
in duplicate. Based on previous studies with elk sera, a delta mP value (defined
as the mean mP value of the sample minus the mean mP value of the negative
control) of 10 was scored as positive. A delta mP value of 10 was scored as
negative.
Statistical analysis. ELISA data were analyzed by independent (infected
versus noninfected) and paired (pre- versus post-skin testing) t tests, using a
commercially available statistics program (MedCalc version 8.1.0.0; MedCalc
Software, Mariakerke, Belgium). A P value of 0.05 was considered significant.
RESULTS
Serological response to crude mycobacterial antigens. Eval-
uation by ELISA of sequential serum specimens collected over
the course of the infection study revealed significant (P  0.05)
antibody responses to M. bovis-derived LAM as early as 56
days p.i. (Fig. 1A). Antibody levels remained greater than
those in control animals for the remainder of the infection
study. A significant boost in antibody was seen following ad-
ministration of tuberculin skin testing at 184 days p.i. (P 
0.05). The mean ( standard error) ELISA OD responses of
infected animals increased from 0.86  0.26 prior to skin
testing (171 days p.i.) to 1.82  0.19 1 week after skin testing
(192 days p.i.). The time courses of antibody responses for
most individual animals were characterized by multipeak ki-
netics (data not shown). Levels of serum antibodies to bovine
tuberculin (PPD-bovis) were also detected by ELISA but, in
this case, were not significantly different from those in control
animals until after skin testing (Fig. 1B). Three of the ten M.
bovis-inoculated cervids had no observable IgG responses to
PPD-bovis throughout the infection study (data not shown).
Immunoblotting of M. bovis WCS with the sera of infected
cervids demonstrated variable initial responses that were ob-
served as early as 44 days p.i. for some animals. Specific bands
of reactivity at 20, 	25, 	33, 	42, and 	75 kDa were consis-
tently observed, with additional bands occasionally detected at
20 and 
100 kDa (Fig. 2A). Responses were boosted both in
intensity and in number of bands by injection of PPDs for the
CCT. Responses to WCS prior to M. bovis infection and during
the infection study for some noninfected cervids demonstrated
the cross-reactivity to the crude antigen mixture (data not
shown).
Serological responses to purified proteins. MAPIA per-
formed on sequentially collected serum samples revealed variable
individual animal antigen recognition patterns with respect to
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both response kinetics and spectrum of antigen reactivity. Exam-
ples of MAPIA strips collected from infected cervids representing
different antigen reactivity patterns are shown in Fig. 3, and the
results for all animals are summarized in Table 1. Infected ani-
mals produced IgG antibodies starting at variable time points p.i.,
but for several animals, IgG antibodies were noted as early as 44
days p.i. Animal no. 36 showed strong and early (44 days p.i.)
serum reactivity to ESAT-6, CFP10 and the corresponding hybrid
fusion protein (Fig. 3). In contrast, animal no. 37 showed no
antibody response to these antigens but reacted early (44 days
p.i.) and consistently to MPB83. For some animals, there was a
change in antigen immunodominance pattern over the infection
period. For example, antibody from the serum of animal no. 44
transiently recognized MPB83 at days 44, 56, 72, and 86 p.i. A few
weeks later, antibody response to MPB83 declined, whereas an-
tibodies to ESAT-6, CFP10, and the corresponding fusion protein
increased and became further pronounced post-skin testing.
Despite the variability, MPB83 was clearly the serodominant
antigen, being recognized in 9 of 10 and 10 of 10 M. bovis-
inoculated animals pre- and post-skin testing, respectively (Ta-
ble 2). Antibodies to MPB83 were detected in some animals as
early as 44 days p.i. by MAPIA, compared to 30 days p.i. for
immunoblotting (Fig. 2B). For comparison, two complex my-
cobacterial antigens (PPD and MBCF) were included in the
MAPIA and were recognized, at least at some time points, by
8 of 10 infected animals, which correlated with the PPD ELISA
results. Notably, however, antibody to MBP83 was elicited
prior to that of either PPD or MBCF (Fig. 3). Other antigens
that were highly reactive by MAPIA included MPB70 (7/10
animals), CFP10 (7/10 animals), and ESAT-6 (8/10 animals)
(Table 1). Only a few reactors against the MPB64, MPB59, and
38-kDa proteins were found, and the Acr1 protein elicited no
antibody response. The Acr1/MPB83 fusion protein did not
react with any more animals than did MPB83 alone. In con-
trast, the ESAT-6/CFP10 fusion protein reacted with 8 of 10
infected cervids prior to skin testing, demonstrating greater
reactivity than either of the constituent proteins alone. Impor-
FIG. 1. Response kinetics of serum antibodies specific for M. bovis
LAM-enriched antigen and PPD-bovis. Sera from M. bovis-inoculated
(f, n  10) and noninoculated (, n  5) elk-red deer hybrids (Cervus
elaphus) were analyzed for reactivity to M. bovis-derived LAM (A) and
PPD-bovis (B) by ELISA. Results are presented as mean ( standard
error of the mean) OD readings (i.e., LAM response minus no
antigen response) (A) and mean ( standard error of the mean) slope
values (milli-OD values [mOD]) as measured by kinetic ELISA (B). 
indicates antibody responses to LAM or PPD-bovis antigen that differ
(P  0.05) from the levels for control animals, and “a” indicates
antibody responses of infected animals that differ (P  0.05) from the
levels observed immediately prior to administration of tuberculin for
CCT at 184 days p.i.
FIG. 2. Immunoblot of M. bovis 93-1315 WCS (A) and MPB83
(B) antigen probed with sera from cervids experimentally infected with
M. bovis. The data presented are from a representative elk-red deer
hybrid (Cervus elaphus) experimentally infected with 1.5 103 CFU of
M. bovis. Molecular mass (MW) markers are indicated in the left
margin, and numbers of days p.i. are indicated in the lower margin.
CCT was performed at 184 days p.i.
VOL. 15, 2008 ANTIBODY RESPONSES OF CERVIDS TO BOVINE TUBERCULOSIS 1653
 at D
igiT
op -- U
S
D
A
's D
igital D
esktop Library on A
pril 12, 2010 
cdli.asm
.org
D
ow
nloaded from
 
tantly, a combination of all antigens detected all inoculated
animals (10 of 10) at some point p.i. As was the case for the
ELISA and immunoblotting experiments, injection of myco-
bacterial antigens at the time of intradermal tuberculin injec-
tion for skin testing boosted antibody responses to several
antigens since MAPIA bands became more intense. Moreover,
in some animals, additional bands appeared only after skin
testing, showing tuberculin-induced antibodies to MPB83,
ESAT-6, CFP10, MPB59, and MPB64. This resulted in an
overall increase in the number of inoculated animals respond-
ing to particular antigens at all time points post-skin testing
FIG. 3. Differential antibody responses of cervids experimentally infected with M. bovis to recombinant antigens detected by MAPIA. The
responses of 4 of 10 M. bovis-infected animals (no. 36, 37, 44, and 51) are presented to illustrate the variability in antigen recognition patterns
between animals. Each panel of strips shows results obtained with a set of sequential serum samples; each strip represents one serum sample
collected at the time p.i. indicated. Bands on the MAPIA strips indicate the presence of antibodies to antigens printed onto a membrane (the
antigens evaluated are listed on the right margin). CCT was performed at 184 days p.i.
TABLE 1. Variable antibody responses to protein antigens as
detected by MAPIA for cervids experimentally infected
with M. bovis
Antigen
Responsea for indicated animal no.
36 37 40 41 44 48 51 116 118 119
ESAT-6          
CFP10          
MPB64          
MPB59          
MPB70          
MPB83          
Acr1          
38-kDa protein          
ESAT-6/CFP10          
Acr1/MPB83          
PPD-b          
MBCF          
a  and  indicate the presence and absence of circulating IgG antibodies
over the 7-month infection period as detected by MAPIA for antigens of M.
bovis/M. tuberculosis.
TABLE 2. Antigen recognition by serum antibodies of cervids
infected with M. bovis as determined by MAPIA
Antigen
No. of antibody reactorsa (n  10)
Pre-skin testing Post-skin testing
ESAT-6 7 8
CFP10 6 7
MPB64 2 2
MPB59 3 4
MPB70 6 7
MPB83 9 10
Acr1 0 0
38-kDa protein 3 4
CFP10/ESAT-6 8 9
Acr1/MPB83 7 9
a Values indicate the maximal rates of antigen recognition among infected
animals as measured before and after CCT performed at 184 days p.i.
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(Table 2). In particular, the numbers of responders to MPB83
and the ESAT-6/CFP10 fusion protein were 10 of 10 (100%)
and 9 of 10 (90%), respectively, post-skin testing. The MAPIA
responses were highly specific in that antibodies specific to M.
bovis antigens were not found in the preinoculation sera or
with the sera of uninfected control animals before or after skin
testing (no false positives).
Evaluation of rapid antibody tests. The diagnostic perfor-
mance levels of two rapid serodiagnostic tests were evaluated
and compared to those for the MAPIA responses. The first, a
lateral-flow test (CervidTB STAT-PAK), detected the anti-
body responses to multiple antigens, including MPB83,
ESAT-6, and CFP10. These antigens were selected based on
MAPIA results that, when combined, would be sufficient to
cover animal-to-animal variation in antibody reactivity pat-
terns. The second rapid test, an FPA, was developed to detect
the antibody response to a single antigen (MPB70). Each test
was evaluated with the same serum samples collected from the
experimentally infected cervids over the course of the experi-
mental infection. The abilities of the two rapid tests to detect
M. bovis-infected animals were compared to the ability of the
MAPIA at every test point (Table 3). In addition, a composite
diagnostic sensitivity was determined, covering testing over the
entire infection study. The lateral-flow test was able to detect
serum antibody as early as 30 days after challenge, followed by
consistent antibody detection in 7 to 8 of 10 infected animals
over the following 23 weeks. The administration of tuberculin
skin testing resulted in increased positivity, with 8 or 9 of 10
infected animals detected over the 4 weeks following the skin
test. Overall, the lateral-flow test produced a composite infec-
tion study sensitivity of 73%. In contrast, the MPB70-specific
FPA detected infected animals much later (86 days p.i.) did not
exceed a sensitivity of 6 of 10 animals detected at any time
during the infection study and had a composite infection study
sensitivity of 33%. For comparison purposes, the MAPIA de-
tected 2 of 10 infected animals as early as 30 days p.i., with 9
and 10 of 10 inoculated animals correctly identified as infected
pre- and post-skin testing, respectively (Table 3). The overall
infection study sensitivity for the MAPIA was 77%. The sero-
logical performance levels of the rapid tests were in agreement
with the MAPIA results obtained on the same set of sera for
the respective antigens. As for the MAPIA, both rapid test
assays were highly specific in that at no time point were control
animals incorrectly categorized as infected (no false positives).
DISCUSSION
This report characterizes the antigen recognition patterns to
multiple mycobacterial antigens during experimental M. bovis
infection of cervids (red deer-elk hybrids) and evaluates the
utility of two rapid tests for the detection of infection. The
kinetics of antibody response to LAM, a glycolipid present in
large quantities on the surface of M. bovis, has been evaluated
in studies of several species and was initially considered a
useful candidate antigen for TB diagnosis (9, 40). Responses to
the LAM-enriched antigen, however, were found to be broadly
cross-reactive with nontuberculous mycobacteria and other
closely related bacterial species. This effect was observed in the
present study, where antibody to LAM was detected in some
animals prior to M. bovis infection and in some control animals
over the course of the study. For TB diagnostic applications,
this cross-reactivity highlights the need for more-specific sero-
logical antigens for identification of M. bovis-infected animals,
as it is likely that many captive and free-ranging cervids will
have been exposed to environmental nontuberculous mycobac-
teria.
The use of individual purified proteins unique to M. bovis
can improve the specificity of antibody-based TB tests but
comes at the expense of diagnostic sensitivity. Employing mul-
tiple protein antigens covering a broad antigenic repertoire has
shown promise in overcoming this limitation. The MAPIA is a
powerful tool in identifying the most-frequently recognized
antigens over the course of experimental M. bovis infection for
a given host species. The result of this study was the identifi-
cation of seroreactive targets not previously reported for red
deer or elk TB. Variable animal-to-animal and temporal anti-
gen recognition patterns consistent with previous observations
made in studies of tuberculous cattle (27), badgers (11), and
white-tailed deer (45) were observed. Importantly, however,
the complete panel of proteins reacted with sera from all
infected animals. Despite this variability, the 25-kDa antigen
(MPB83) either alone or as a fusion partner with the 16-kDa
alpha-crystalline (Acr1) protein was clearly the serodominant
antigen, eliciting responses in 9 and 10 of 10 cervids pre- and
post-skin testing, respectively. This surface-associated antigen
of M. bovis has also been shown to be serodominant for white-
tailed deer (45), reindeer (44), and Eurasian badgers (11).
Interestingly, the one animal (no. 48) that did not react to the
Acr1/MPB8 fusion protein did produce a response to the single
MPB83 recombinant. This may have been the result of epitope
inaccessibility in the generation of the fusion protein. In the
present study, MPB83 responses were detected early and gen-
erally increased over time after inoculation. In all cases, anti-
body to MPB83 was elicited prior to that of either PPD or
MBCF, both of which are complex mycobacterial antigens.
Additional highly reactive antigens included ESAT-6 and
CFP10, which are immunogenic low-molecular-mass proteins
secreted by virulent M. tuberculosis and M. bovis (38, 39).
TABLE 3. Summary of diagnostic serological responses as determined by different methods for sera of cervids (C. elaphus)
experimentally infected with M. bovis
Test method
Rate (no. of animals with antigen/total no. of animals)a for indicated no. of days p.i. Overall sensitivity
(%)b30 44 58 72 86 114 140 171 192 199 206 213
MAPIA 2/10 6/10 8/10 8/10 8/10 8/10 8/10 8/10 9/10 9/10 9/10 9/10 76.7
Lateral flow 2/10 5/10 9/10 7/10 7/10 7/10 7/10 8/10 8/10 9/10 9/10 9/10 72.5
FPA 0/10 0/10 0/10 0/10 3/10 4/10 6/10 5/10 6/10 6/10 5/10 5/10 33.3
a Values indicate rates of antigen recognition among infected animals as measured at various time points p.i. Tuberculin skin testing was performed at 184 days p.i.
b A composite diagnostic sensitivity based on all time points sampled over the infection study.
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These antigens are highly specific to the M. tuberculosis com-
plex and thus have demonstrated potential to improve test
specificity. In the present study, the ESAT-6/CFP10 fusion
protein showed greater reactivity by MAPIA than did corre-
sponding single proteins, demonstrating the potential of poly-
epitope fusions in developing a serodiagnositic test for TB.
This phenomenon was previously reported in human (19), bad-
ger (11), and white-tailed deer (45) studies. The M. tuberculosis
complex CFP10 and ESAT-6 antigens have been shown to
form a 1:1 heterocomplex potentially displaying additional
conformation epitopes (35). Interestingly, the high rate of se-
roreactivity to ESAT-6/CFP10 reported here contrasts with
recent studies of white-tailed deer (45) and reindeer (44) that
showed much lower levels of seroreactivity (	30%) for the
same hybrid protein.
Several other antigens, including MPB59, MPB64, and the
38-kDa protein, showed lower seroreactivity (2 or 3 of 10
animals). Although the 38-kDa protein is the most potent
B-cell antigen in human TB (23), only 30% seroreactivity was
observed in this study. It was surprising and important to note
that no tuberculous animals recognized the 16-kDa Acr1 pro-
tein, since previous studies with cattle, white-tailed deer, and
reindeer have all demonstrated seroreactivity (27, 44, 45).
These findings illustrate the need to determine antigen recog-
nition patterns in response to M. bovis infection for each spe-
cies of interest.
A scientific paradigm held for decades was the belief that
host defense to TB was primarily a function of cell-mediated
immunity but that antibody played little or no protective role.
Consistent with this paradigm was the early observation that
serodiagnostic methods, in contrast to cell-mediated response
assays, were able to detect antibody responses only at the later
stages of TB agent infection. It is now recognized, however,
that the immune response to any particular microorganism is
neither strictly cell mediated nor antibody mediated in nature
but rather involves a spectrum of reactivity. Indeed, several
recent studies have demonstrated early antibody responses
with beneficial effects on various aspects of TB agent infection
(3, 48). In the present study, antibodies to some antigens,
including MPB83, ESAT-6, and CFP10, were detected at low
levels as early as 4 weeks after experimental infection. This was
as early as the cell-mediated immune responses measured as
part of this study but reported elsewhere (14). In contrast,
seroreactivity to other antigens, including MPB70, a secreted
stable protein of M. bovis and active component of bovine
tuberculin (13), was detected much later in the infection period
(
86 days).
To control and eradicate bovine TB from free-ranging and
captive wildlife, it would be advantageous to apply rapid tests
to surveillance programs that are low in cost and can be per-
formed outside the laboratory (i.e., “animal-side”). Although
numerous attempts to develop a rapid serodiagnostic test for
human TB have been disappointing, the potential of this ap-
proach for TB detection in animals has recently been demon-
strated (11, 25, 26). The MAPIA data of the present study have
implications for the application of such test methods to C.
elaphus. The variable response kinetics between antigens and,
for some animals, the changing antigen recognition patterns
over time will require a high-sensitivity test to include a cock-
tail of carefully selected antigens covering the broadest spec-
trum of antibody reactivity in a population. This study suggests
that such a cocktail should include at least MPB83, ESAT-6,
and CFP10.
The evaluation of the serological rapid tests, each with po-
tential for animal-side application, supported the above con-
clusions. Each test used a small amount of serum or plasma
and provided results within minutes. The lateral-flow immu-
noassay detected reactivity to a mixture of antigens, including
ESAT-6, CFP10, and MPB83, whereas the FPA utilized
MPB70 as a single diagnostic antigen. The MPB70 protein is
secreted from M. bovis, forms a major component of M. bovis
culture filtrate, is an active component of PPD tuberculin (13,
30), and is a dominant B-cell target in tuberculous cattle (8).
Importantly, the selected antigens for both assays are highly
specific for the M. tuberculosis complex, thus providing the
necessary basis for a highly specific TB serodiagnostic test.
Indeed, this was supported by the lack of reactivity in control
animals over the study period. Both rapid tests detected serum
antibodies in infected animals over the course of the infection
study. The multiantigen lateral-flow test started to detect in-
fected animals as early as 30 days p.i. (Table 3) and was able to
detect antibodies from all infected animals at some point over
the infection period. In contrast, it was not until 86 days p.i.
that the MPB70 FPA started to classify infected animals as
reactors, and 3 of 10 animals did not show any reactivity toward
MPB70. The late reactivity to the MPB70 antigen was consis-
tent with the MAPIA results for the same sera. Over the course
of the infection study, the lateral-flow assay compared favor-
ably to the MAPIA, with composite infection study sensitivities
of 73% and 77%, respectively. This contrasted with the low
composite sensitivity of the FPA, at 33%. Previously, serore-
activity to MPB70 has been high for TB agent-infected cattle
(27), and the FPA was demonstrated to have a high diagnostic
sensitivity (93%) for detecting Canadian cattle naturally in-
fected with M. bovis (41). The comparatively low diagnostic
sensitivity for cervids noted in this study suggests that there are
significant species differences with respect to seroreactivity to
MPB70. This finding further illustrates the variability of anti-
gen recognition patterns between species and the advantage of
incorporating multiple seroreactive antigens for TB diagnosis.
Tuberculin skin testing at 184 days p.i. resulted in elevated
antibody responses by ELISA, immunoblot analysis, and
MAPIA and increased the rates of disease detection by the rapid
tests during the 4-week testing period post-skin testing. Such
anamnestic antibody responses to mycobacterial antigens were
initially recognized in early bovine TB control programs (17)
and have periodically been rediscovered over the years (13,
49). For cattle, the boosted immunoglobulin responses post-
skin testing have been shown to be an anamnestic IgG1 re-
sponse (21) and to involve a number of antigens that are
presumably present in tuberculin (13, 24). This phenomenon
has been similarly reported in studies of various other species,
including white-tailed deer and reindeer (44, 45). If this en-
hanced sensitivity is also found to be diagnostically specific, the
boosting of M. bovis-specific antibody responses by skin testing
could be exploited to improve TB serodiagnosis of captive
wildlife. For example, a highly specific serological TB test
could be used following standard skin-testing procedures (i.e.,
as a complementary or confirmatory test), which would serve
to decrease the number of animals slaughtered due to false-
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positive skin test reactions. This approach, however, would
prove impractical for free-ranging wildlife, as it requires an
additional capture and handling of each animal following skin
testing to collect serum and read the skin test.
It is likely that the diagnostic performance of serological
rapid tests can be further improved. This study evaluated only
a select group of protein antigens secreted by M. bovis. Re-
cently, a TB-antigen microarray was used to screen human TB
patients for antibodies to 54 oligosaccharides, polysaccharides,
and lipopolysaccharides, TB antigens achieving high discrimi-
natory power (43). In addition, other testing formats, such as
latex bead agglutination assays, have also shown promise in TB
serodiagnostics (18). The inclusion of the optimal mix of pro-
teins, fusion proteins, lipoproteins, and lipopolysaccharides to
enhance sensitivity, taken with the continuing miniaturization
of serological assay formats, would seem to hold promise for
the future of animal-side TB diagnostics. Ultimately, the main
usage of such tests may be to monitor the prevalence of disease
in various wildlife populations, to screen animals prior to entry
into disease-free herds, or to monitor the spread of infection in
zoological parks. The infection model used in this study pro-
duced tuberculous lesions with no associated clinical signs and
thus closely mimics the disease state in naturally infected an-
imals without advanced disease. A question remains, however,
as to how well this model reflects all aspects of the disease
process and the range of responses present in a naturally in-
fected free-ranging population. Additional studies with greater
numbers of well-defined positive and negative samples from
naturally exposed cervids are required to evaluate these and
other emerging antibody-based diagnostic platforms. In addi-
tion, further work is required to extend the application to other
wildlife species of interest.
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